RTW Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

RTW Investments’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,515,788	Closed	-$42.8M	–	119
2020 Q4	$42.8M	Buy	+2,515,788	New	+$31.5M	0.72%	37
2018 Q1	–	Sell	-100,377	Closed	-$2.2M	–	44
2017 Q4	$2.2M	Buy	+100,377	New	+$3.23M	0.37%	29
2016 Q4	–	Sell	-44,044	Closed	-$2.31M	–	38
2016 Q3	$2.31M	Sell	44,044 -657	-1%	-$31.4K	0.7%	25
2016 Q2	$1.85M	Sell	44,701 -182,297	-80%	-$7.93M	0.63%	24
2016 Q1	$9.22M	Sell	226,998 -30,238	-12%	-$1.04M	3.35%	11
2015 Q4	$10.7M	Sell	257,236 -456,718	-64%	-$15.3M	3.47%	10
2015 Q3	$11M	Buy	713,954 +153,517	+27%	+$3.3M	3.41%	11
2015 Q2	$13.9M	Buy	+560,437	New	+$12.5M	4.05%	12

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

RTW Investments's FPRX Position: Q1 2021 in Review

RTW Investments sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 2,515,788 shares — an estimated $42.8M sold.

RTW Investments first reported a position in FPRX in Q2 2015 and held it in 8 quarters. The position peaked at $42.8M in Q4 2020. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

RTW Investments reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
RTW Investments sold 2,515,788 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $42.8M.
RTW Investments first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 8 quarters.
RTW Investments's Five Prime Therapeutics, Inc. position peaked at $42.8M in Q4 2020.
147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on RTW Investments's 13F filing for Q1 2021, filed 14 May 2021.